Rankings
▼
Calendar
ACET (Adicet Bio, Inc.) Stock Financials & Earnings | Market Cap Arena
ACET
Adicet Bio, Inc.
Mkt Cap
$76M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
-$115M
EPS (TTM)
-$20.16
Free Cash Flow (TTM)
-$100M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q3 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q4 22
$0
$0
-$32M
Q1 23
$0
$0
-$33M
Q2 23
$0
$0
-$35M
Q3 23
$0
$0
-$52M
Q4 23
$0
$0
-$32M
Q1 24
$0
-$2M
-$31M
Q2 24
$0
$0
-$33M
Q3 24
$0
$0
-$33M
Q4 24
$0
$0
-$31M
Q1 25
$0
$0
-$30M
Q2 25
$0
$0
-$32M
Q3 25
$0
$0
-$28M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q4 22
3.0x
—
Q1 23
—
—
Q2 23
—
—
Q3 23
—
—
Q4 23
—
—
Q1 24
—
—
Q2 24
—
—
Q3 24
—
—
Q4 24
—
—
Q1 25
—
—
Q2 25
—
—
Q3 25
—
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q4 22
-$19M
-$25M
Q1 23
-$24M
-$26M
Q2 23
-$25M
-$26M
Q3 23
-$21M
-$22M
Q4 23
-$23M
-$24M
Q1 24
-$23M
-$23M
Q2 24
-$23M
-$24M
Q3 24
-$22M
-$22M
Q4 24
-$24M
-$24M
Q1 25
-$25M
-$27M
Q2 25
-$27M
-$27M
Q3 25
-$22M
-$23M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q4 22
$6M
Q1 23
$2M
Q2 23
$2M
Q3 23
$906K
Q4 23
$136K
Q1 24
$239K
Q2 24
$302K
Q3 24
$401K
Q4 24
$176K
Q1 25
$1M
Q2 25
$47K
Q3 25
$209K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q4 22
-100.0%
+50.2%
Q1 23
-100.0%
+64.3%
Q2 23
—
+53.7%
Q3 23
—
+127.4%
Q4 23
—
+0.0%
Q1 24
—
-7.4%
Q2 24
—
-5.8%
Q3 24
—
-36.6%
Q4 24
—
-2.6%
Q1 25
—
-3.2%
Q2 25
—
-1.4%
Q3 25
—
-15.7%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q4 22
$4M
—
Q1 23
$5M
—
Q2 23
$5M
—
Q3 23
$6M
—
Q4 23
$5M
—
Q1 24
$6M
—
Q2 24
$6M
—
Q3 24
$7M
—
Q4 24
$4M
—
Q1 25
$3M
—
Q2 25
$3M
—
Q3 25
$3M
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q4 22
$25M
$7M
Q1 23
$27M
$7M
Q2 23
$28M
$7M
Q3 23
$26M
$7M
Q4 23
$25M
$7M
Q1 24
$24M
$7M
Q2 24
$26M
$7M
Q3 24
$26M
$7M
Q4 24
$23M
$7M
Q1 25
$23M
$7M
Q2 25
$28M
$4M
Q3 25
$23M
$5M
marketcaparena.com
Revenue Segments
Quarter
marketcaparena.com
Revenue by Geography
Quarter
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q4 22
$258M
$0
$258M
Q1 23
$232M
$0
$232M
Q2 23
$205M
$0
$205M
Q3 23
$183M
$0
$183M
Q4 23
$160M
$0
$160M
Q1 24
$248M
$0
$248M
Q2 24
$224M
$0
$224M
Q3 24
$105M
$97M
$202M
Q4 24
$56M
$120M
$176M
Q1 25
$28M
$122M
$150M
Q2 25
$35M
$90M
$125M
Q3 25
$29M
$74M
$103M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q4 22
3M
+0.0%
Q1 23
3M
+3.1%
Q2 23
3M
+0.0%
Q3 23
3M
+0.1%
Q4 23
3M
+0.1%
Q1 24
5M
+83.7%
Q2 24
6M
+14.6%
Q3 24
6M
+0.2%
Q4 24
5M
-3.3%
Q1 25
6M
+3.6%
Q2 25
6M
+0.0%
Q3 25
6M
+0.0%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 13
—
—
FY 14
—
—
FY 15
—
—
FY 16
—
—
FY 17
—
—
FY 18
$390K
21
FY 19
$55K
18
FY 20
$221K
81
FY 21
$113K
86
FY 22
$189K
132
FY 23
$0
143
FY 24
$0
152
marketcaparena.com